FDA panel votes 8-3 Regeneron's (REGN) Arcalyst unsafe in gout flares
Go back to FDA panel votes 8-3 Regeneron's (REGN) Arcalyst unsafe in gout flares| Regeneron (NASDAQ: REGN) | Delayed: 826.33 -7.71 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $834.04 | 52 Week High | $592.36 | |||
| Open | $834.51 | 52 Week Low | $325.35 | |||
| Day High | $834.70 | P/E | 216.88 | |||
| Day Low | $823.40 | EPS | $3.81 | |||
| Volume | 148,452 | |||||

